Company

PAQ Therapeutics

https://www.paqtx.com/

Industryclinical-stage oncology company developing targeted protein degradation therapies for KRAS-driven cancers

Funding raised

CompanyRoundDate
PAQ TherapeuticsSeries B Extension2026-01-26
PAQ TherapeuticsSeries B2025-05-07